LON:MTPHMidatech Pharma Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Midatech Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 24 -0.50 (-2.04 %) (As of 06/4/2020 07:47 AM ET) Add Compare Share Today's Range 23.50Now: GBX 24▼ 2450-Day Range 22MA: GBX 32.22▼ 6252-Week Range 2Now: GBX 24▼ 79.90Volume40,580 shsAverage Volume61,863 shsMarket Capitalization£9.42 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsInsider TradesHeadlines Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates through two segments, Pipeline Research and Development; and Commercial. Its products include Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral gel barrier device indicated for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the treatment and prevention of breast cancer. Midatech Pharma PLC is collaborating with universities and pharmaceutical companies to develop its platform technologies into a range of products. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Midatech Pharma. Previous Next 3.3 Community Rank Outperform VotesMidatech Pharma has received 242 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMidatech Pharma has received 125 “underperform” votes. (Add your “underperform” vote.)Community SentimentMidatech Pharma has received 65.94% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Midatech Pharma and other stocks. Vote “Outperform” if you believe MTPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MTPH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMidatech Pharma does not currently pay a dividend.Dividend GrowthMidatech Pharma does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Midatech Pharma insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Midatech Pharma is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Midatech Pharma is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMidatech Pharma has a P/B Ratio of 0.20. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.79 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:MTPH Previous Symbol CUSIPN/A CIKN/A Webwww.midatechpharma.com Phone+44-1235-841575Debt Debt-to-Equity Ratio4.42 Current Ratio4.21 Quick Ratio3.83Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£1.84 million Price / Sales5.12 Cash FlowGBX 43.80 per share Price / Cash Flow0.55 Book ValueGBX 120.90 per share Price / Book0.20Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees73 Outstanding Shares39,252,600Market Cap£9.42 million Next Earnings DateN/A OptionableNot Optionable LSE:MTPH Rates by TradingView Receive MTPH News and Ratings via Email Sign-up to receive the latest news and ratings for MTPH and its competitors with MarketBeat's FREE daily newsletter. Midatech Pharma (LON:MTPH) Frequently Asked Questions How has Midatech Pharma's stock been impacted by COVID-19 (Coronavirus)? Midatech Pharma's stock was trading at GBX 36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MTPH shares have decreased by 33.3% and is now trading at GBX 24. View which stocks have been most impacted by Coronavirus. How were Midatech Pharma's earnings last quarter? Midatech Pharma PLC (LON:MTPH) posted its quarterly earnings data on Thursday, September, 28th. The company reported ($19.00) earnings per share (EPS) for the quarter. The company had revenue of $3.02 million for the quarter. View Midatech Pharma's earnings history. Has Midatech Pharma been receiving favorable news coverage? News coverage about MTPH stock has been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Midatech Pharma earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutMidatech Pharma. Who are some of Midatech Pharma's key competitors? Some companies that are related to Midatech Pharma include Microbix Biosystems (MBX), Oragenics (OGEN), IntelGenx Technologies (IGX), Proteomics Int Lab (PIQ), Ixico (IXI), Pharmaust (PAA), Aerpio Pharmaceuticals (ARPO), Actinium Pharmaceuticals (ATNM), Kazia Therapeutics (KZA), NovaBay Pharmaceuticals (NBY), Biocardia (BCDA), Nuformix (NFX), ImmuPharma (IMM), Noxopharm (NOX) and Hemogenyx Pharmaceuticals (HEMO). View all competitors. What other stocks do shareholders of Midatech Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Midatech Pharma investors own include Aldeyra Therapeutics (ALDX), Barclays (BARC), Telefonaktiebolaget LM Ericsson (ERIC), Futura Medical (FUM), Lloyds Banking Group (LLOY), Pearson (PSON), Royal Mail (RMG), AON (AON), Angus Energy (ANGS) and Advanced Medical Solutions Group (AMS). Who are Midatech Pharma's key executives? Midatech Pharma's management team includes the following people: Mr. Nicholas John Robbins-Cherry, CFO, Company Sec. & Director (Age 50)Dr. Craig Richard Cook, CEO, COO & Director (Age 52)Mr. Rob Rainey FCA MBA MA, Head of Corp. Devel.Dr. Tim Sparey Ph.D., Chief Bus. OfficerMr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QP, Head of Manufacturing What is Midatech Pharma's stock symbol? Midatech Pharma trades on the London Stock Exchange (LON) under the ticker symbol "MTPH." How do I buy shares of Midatech Pharma? Shares of MTPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Midatech Pharma's stock price today? One share of MTPH stock can currently be purchased for approximately GBX 24. How big of a company is Midatech Pharma? Midatech Pharma has a market capitalization of £9.42 million and generates £1.84 million in revenue each year. Midatech Pharma employs 73 workers across the globe. What is Midatech Pharma's official website? The official website for Midatech Pharma is www.midatechpharma.com. How can I contact Midatech Pharma? Midatech Pharma's mailing address is 65 Innovation Drive, Milton Park, ABINGDON, OX14 4RQ, United Kingdom. The company can be reached via phone at +44-1235-841575. This page was last updated on 6/4/2020 by MarketBeat.com Staff
